PAT-048

CAS No. 1359983-15-5

PAT-048 ( PAT 048;PAT048 )

Catalog No. M11477 CAS No. 1359983-15-5

PAT-048 (PAT048) is apotent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 963 Get Quote
50MG 1962 Get Quote
100MG 2520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PAT-048
  • Note
    Research use only, not for human use.
  • Brief Description
    PAT-048 (PAT048) is apotent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX.
  • Description
    PAT-048 (PAT048) is apotent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX; exhibits good potency for inhibition of lysoPLD activity with IC50 of 8.9 nM and 22 nM in human blood and mouse plasma, respectively; decreases ATX activity systemically and in the lung, without effect on pulmonary LPA or fibrosis in bleomycin-challenged mice.
  • Synonyms
    PAT 048;PAT048
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Autotaxin
  • Recptor
    Autotaxin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1359983-15-5
  • Formula Weight
    461.91
  • Molecular Formula
    C22H18ClF2N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCN1N=CC(N2C(C(F)=C(Cl)C=C3)=C3C(SC4=CC=CC(C(O)=O)=C4F)=C2C)=C1
  • Chemical Name
    3-((6-chloro-7-fluoro-2-methyl-1-(1-propyl-1H-pyrazol-4-yl)-1H-indol-3-yl)thio)-2-fluorobenzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Black KE, et al. FASEB J. 2016 Jun;30(6):2435-50.
2. Castelino FV, et al. Arthritis Rheumatol. 2016 Dec;68(12):2964-2974.
3. Bain G, et al. J Pharmacol Exp Ther. 2017 Jan;360(1):1-13.
molnova catalog
related products
  • Autotaxin inhibitor ...

    Autotaxin inhibitor compound 1 (Autotaxin-IN-1) is a potent, selective, orally bioavailable inhibitor of autotaxin with IC50 of 2.2 nM in ex vivo human whole blood assay.

  • GLPG-1690

    GLPG-1690 (Ziritaxestat, GLPG1690) is a first-in-class, potent, competitive autotaxin inhibitor with Ki/IC50 of 15 nM/131 nM.

  • BI-2545

    BI-2545 is a novel potent, selective, orally available Autotaxin inhibitor with IC50 of 2.1 and 3.4 nM for huamn and rat ATX, respectively.